From Suspects to the Spitterati: A collision of power, profit, and privacy
By Jessica Cussins
| 06. 27. 2013
DNA is the ultimate big-data dream. It can shed light on our health, ancestry, and family members. It can be used to solve crimes and exonerate the innocent, investigate diseases and treatments, advance basic scientific knowledge, and reveal certain aspects of our histories and potential futures.
But as genetic data is collected and used in increasingly varied contexts, issues of privacy, rights, access, justice, and innovation are poised to collide – and to intersect our lives in both positive and negative ways. The questions raised by this coming collision won’t be answered immediately, but we need to start now to tease out their complexities.
Many suitors are lining up to exploit the explosion of genetic information.
- Local police agencies are creating their own databases – some call them “rogue” databases – and the Supreme Court recently determined that state and federal authorities can take DNA from people arrested (pre-conviction) for serious crimes.
- Companies are rushing to patent genetic findings, even when such claims are absurd (and now, at least partially, ruled unconstitutional by the Supreme Court).
- Marketing and advertising gurus...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...